People: Fresenius SE & Co KGaA (FREG.DE)
6 Dec 2013
Dr. Ulf Mark Schneider has been Chairman of the Management Board of Fresenius SE & Co KGaA since May 28, 2003. Previously, he was Group Finance Director for Gehe UK PLC, a pharmaceutical wholesale and retail distributor, in Coventry, United Kingdom. Dr. Schneider has held several senior executive positions since 1989 with Gehe's majority shareholder, Franz Haniel & Cie GmbH, a diversified German multinational company. Currently, he serves on the Supervisory Boards of several Fresenius' subsidiaries, as well as Member of the Board of Directors of APP Pharmaceuticals and Inc, FHC (Holdings), Ltd. Dr. Schneider holds a Lic. oec. degree in Finance and Accounting, a Doctorate in Philosophy (Ph.D.) in Economics from Universitaet St. Gallen and a Master of Business Administration degree from Harvard University.
|Total Annual Compensation, EUR||Long-Term Incentive Plans, EUR||All Other, EUR||Fiscal Year Total, EUR|